Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radioembolization”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Not applicableEnded earlyNCT03059030
What this trial is testing

Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia

Who this might be right for
ThrombocytopeniaCirrhosis
Northwestern University 7
Not applicableStudy completedNCT02724436
What this trial is testing

Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaRadioembolization
Eastern Hepatobiliary Surgery Hospital 200
Not applicableEnded earlyNCT03889093
What this trial is testing

Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

Who this might be right for
Hepatocellular CarcinomaSecondary Malignant Neoplasm of Liver
University of Minnesota 14
Testing effectiveness (Phase 2)Ended earlyNCT01381211
What this trial is testing

Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Ghent 72
Early research (Phase 1)Study completedNCT01893099
What this trial is testing

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Who this might be right for
Ocular Melanoma
Centre Hospitalier Universitaire Vaudois 11
Very early researchEnded earlyNCT01730157
What this trial is testing

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+5 more
Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT01469572
What this trial is testing

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Who this might be right for
Neuroendocrine Tumors
Emory University 13
Not applicableLooking for participantsNCT07043387
What this trial is testing

Streamlining Radioembolization for CCC and Metastatic Liver Cancer

Who this might be right for
Metastatic Colorectal Carcinoma (mCRC)Metastatic Liver CancerCholangiocarcinoma
Seoul National University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04124991
What this trial is testing

Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 24
Large-scale testing (Phase 3)Looking for participantsNCT07293468
What this trial is testing

Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tuen Mun Hospital 106
Testing effectiveness (Phase 2)Looking for participantsNCT06432036
What this trial is testing

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Who this might be right for
Stage I Renal Cell CancerStage II Renal Cell Cancer
Jonsson Comprehensive Cancer Center 25
Not applicableLooking for participantsNCT04390724
What this trial is testing

Optimizing Y90 Therapy for Radiation Lobectomy

Who this might be right for
HCCResectionTransplant+2 more
Northwestern University 104
Testing effectiveness (Phase 2)Looking for participantsNCT04339036
What this trial is testing

CapTemY90 for Grade 2/3 NET Liver Metastases

Who this might be right for
Neuroendocrine Tumor Grade 2Neuroendocrine Tumors
Abramson Cancer Center at Penn Medicine 70
Testing effectiveness (Phase 2)Looking for participantsNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami 30
Not applicableLooking for participantsNCT04668872
What this trial is testing

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Who this might be right for
Colon Cancer Liver MetastasisColon CancerAdenocarcinoma of the Colon+3 more
Memorial Sloan Kettering Cancer Center 80
Not applicableUnknownNCT01815879
What this trial is testing

Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project

Who this might be right for
Colorectal CancerLiver Metastases
Andrew Kennedy 1,000
Not applicableActive Not RecruitingNCT03896646
What this trial is testing

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8+4 more
M.D. Anderson Cancer Center 42
Early research (Phase 1)Looking for participantsNCT05701488
What this trial is testing

SIRT With Tremelimumab and Durvalumab for Resectable HCC

Who this might be right for
Resectable Hepatocellular CarcinomaHepatocellular CarcinomaHepatocellular Cancer
Jiping Wang, MD, PhD 20
Not applicableLooking for participantsNCT06873269
What this trial is testing

Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Locally Advanced Hepatocellular CarcinomaLiver CirrhosisNon-metastatic Hepatocellular Carcinoma
Universitair Ziekenhuis Brussel 100
Not applicableStudy completedNCT04172714
What this trial is testing

Low-dose Y90 Treatment Planning for HCC

Who this might be right for
HCCCancer of LiverCancer
Emory University 30
Load More Results